Clinical trial
A Phase 1/2 Two-center, Double-blind, Randomized, Placebo-controlled Multi-period Crossover (N-of-1) Study to Evaluable the Feasibility, Safety, and Efficacy of TJ-68 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps
NCT04998305 is registered in ClinicalTrials.gov with Hiroshi Mitsumoto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Two-center, Double-blind, Randomized, Placebo-controlled Multi-period Crossover (N-of-1) Study to Evaluable the Feasibility, Safety, and Efficacy of TJ-68 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps
- Lead sponsor
- Hiroshi Mitsumoto
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2022
- Completion date
- July 26, 2024
- Enrollment
- 11 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.